Infectious and non-infectious neurologic complications in heart transplant recipients

Medicine

Volumn 89, Issue 3, 2010, Pages 166-175

  Muñoz, Patricia ^a   Valerio, Maricela ^a   Palomo, Jesús ^a   Fernández Yáñez, Juan ^a   Fernández Cruz, Ana ^a   Guinea, Jesús ^a   Bouza, Emilio ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; AMPICILLIN; AZATHIOPRINE; CEFAZOLIN; CEFTRIAXONE; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOSPORIN A; DACLIZUMAB; ETHAMBUTOL; EVEROLIMUS; GANCICLOVIR; IMMUNOGLOBULIN; ISONIAZID; ITRACONAZOLE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NORFLOXACIN; OKT 3; PNEUMOCOCCUS VACCINE; PYRIMETHAMINE; RIFAMPICIN; SULFADIAZINE; TACROLIMUS; THYMOCYTE ANTIBODY; VANCOMYCIN;

ADULT; AGED; ASPERGILLOSIS; BACTERIAL MENINGITIS; BRACHIAL PLEXUS NEUROPATHY; BRAIN DISEASE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BRAIN LYMPHOMA; CARDIAC GRAFT REJECTION; CENTRAL NERVOUS SYSTEM ASPERGILLOSIS; CENTRAL NERVOUS SYSTEM INFECTION; CENTRAL NERVOUS SYSTEM TUBERCULOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; GRAFT INFECTION; HEART TRANSPLANTATION; HERPES ZOSTER; HUMAN; INCIDENCE; LISTERIOSIS; LOADING DRUG DOSE; LUNG ASPERGILLOSIS; MALE; METABOLIC ENCEPHALOPATHY; MORBIDITY; MORTALITY; MYOCLONUS; NEUROLOGIC DISEASE; NEUROPATHY; PNEUMOCOCCAL INFECTION; PNEUMOCOCCAL MENINGITIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SEIZURE; SUBDURAL HEMATOMA; TOXOPLASMOSIS; TRANSIENT ISCHEMIC ATTACK;

ANTIBODIES, MONOCLONAL; CENTRAL NERVOUS SYSTEM DISEASES; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HERPES ZOSTER; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; MALE; MENINGITIS, LISTERIA; MENINGITIS, PNEUMOCOCCAL; MIDDLE AGED; MUROMONAB-CD3; NEUROASPERGILLOSIS; OPPORTUNISTIC INFECTIONS; PREVALENCE; RETROSPECTIVE STUDIES; TOXOPLASMOSIS, CEREBRAL; TUBERCULOSIS, CENTRAL NERVOUS SYSTEM;

EID: 77952172523     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/MD.0b013e3181dfa59c     Document Type: Review

References (35)

1. Aguado JM, Detarsio F, Lopez-Medrano F, San Juan R. Infecciones por microorganismos menos comunes. In: Aguado JM, ed. Infecciones en Pacientes Trasplantados. 2nd ed. Madrid: Elsevier; 2004:559-593.
2. Aguado JM, Torre-Cisneros J, Fortun J, Benito N, Meije Y, Doblas A, Munoz P. Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology. Clin Infect Dis. 2009;48:1276-1284.
3. Andrews BT, Hershon JJ, Calanchini P, Avery GJ II, Hill JD. Neurologic complications of cardiac transplantation. West J Med. 1990;153: 146-148.
4. Ang LC, Gillett JM, Kaufmann JC. Neuropathology of heart transplantation. Can J Neurol Sci. 1989;16:291-298.
5. Barnhart E. Cyclosporine: product information. In: Physicians-s Desk Reference. Oradell, NJ: Medical Economics; 1989.
6. Bashir RM. Neurologic complications of organ transplantation. Curr Treat Options Neurol. 2001;3:543-554.
7. Beniaminovitz A, Itescu S, Lietz K, Donovan M, Burke EM, Groff BD, Edwards N, Mancini DM. Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody. N Engl J Med. 2000;342:613-619.
8. Cemillan CA, Alonso-Pulpon L, Burgos-Lazaro R, Millan-Hernandez I, del Ser T, Liano-Martinez H. ENeurological complications in a series of 205 orthotopic heart transplant patients-. Rev Neurol. 2004;38: 906-912.
9. Ernst ME, Franey RJ. Acyclovir-and ganciclovir-induced neurotoxicity. Ann Pharmacother. 1998;32:111-113.
10. Gurgui M, Puig M. Infecciones por bacterias y hongos en trasplante cardiaco. In: Aguado JM, ed. Infecciones en Pacientes Trasplantados. 2nd ed. Madrid: Elsevier; 2004:445-470.
11. Hershberger RE, Starling RC, Eisen HJ, Bergh CH, Kormos RL, Love RB, Van Bakel A, Gordon RD, Popat R, Cockey L, Mamelok RD. Daclizumab to prevent rejection after cardiac transplantation. N Engl J Med. 2005;352:2705-2713.
12. Hotson JR, Enzmann DR. Neurologic complications of cardiac transplantation. Neurol Clin. 1988;6:349-365.
13. Hotson JR, Pedley TA. The neurological complications of cardiac transplantation. Brain. 1976;99:673-694.
14. Hovens MM, Vaessen N, Sijpkens YW, de Fijter JW. Unusual presentation of central nervous system manifestations of varicella zoster virus vasculopathy in renal transplant recipients. Transpl Infect Dis. 2007;9:237-240.
15. Jarquin-Valdivia AA, Wijdicks EF, McGregor C. Neurologic complications following heart transplantation in the modern era: decreased incidence, but postoperative stroke remains prevalent. Transplant Proc. 1999;31:2161-2162.
16. Kobashigawa J, David K, Morris J, Chu AH, Steffen BJ, Gotz VP, Gordon RD. Daclizumab is associated with decreased rejection and no increased mortality in cardiac transplant patients receiving MMF, cyclosporine, and corticosteroids. Transplant Proc. 2005;37: 1333-1339.
17. Loire R, Tabib A, Bastien O. EFatal aspergillosis after cardiac transplantation. About 26 cases-. Ann Pathol. 1993;13:157-163.
18. Lumbreras C, Cisneros JM, Munoz P. Protocolos Clinicos. Infecciones en el paciente trasplantado. In: Aguado JM, Fortun J, eds. Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica. Madrid: Adalia; 2007:411-447.
19. Malheiros SM, Almeida DR, Massaro AR, Castelo A, Diniz RV, Branco JN, Carvalho AC, Gabbai AA. Neurologic complications after heart transplantation. Arq Neuropsiquiatr. 2002;60:192-197.
20. Montero CG, Martinez AJ. Neuropathology of heart transplantation: 23 cases. Neurology. 1986;36:1149-1154.
21. Munoz P, Arencibia J, Rodriguez C, Rivera M, Palomo J, Yanez J, Bouza E. Trimethoprim-sulfamethoxazole as toxoplasmosis prophylaxis for heart transplant recipients. Clin Infect Dis. 2003;36:932-923; author reply 933.
22. Munoz P, Palomo J, Munoz R, Rodriguez-Creixems M, Pelaez T, Bouza E. Tuberculosis in heart transplant recipients. Clin Infect Dis. 1995;21:398-402.
23. Munoz P, Rodriguez C, Bouza E, Palomo J, Yanez JF, Dominguez MJ, Desco M. Risk factors of invasive aspergillosis after heart transplantation: protective role of oral itraconazole prophylaxis. Am J Transplant. 2004;4:636-643.
24. Perez-Miralles F, Sanchez-Manso JC, Almenar-Bonet L, Sevilla-Mantecon T, Martinez-Dolz L, Vilchez-Padilla JJ. Incidence of and risk factors for neurologic complications after heart transplantation. Transplant Proc. 2005;37:4067-4070.
25. Peterson LR, Ferguson RM. Fatal central nervous system infection with varicella-zoster virus in renal transplant recipients. Transplantation. 1984;37:366-368.
26. Petrikovits E, Bedanova H, Necas J, Studenik P, Cerny J. Daclizumab in the induction phase of immunosuppression in heart transplant recipients. Ann Transplant. 2005;10:5-10.
27. Pratt G, Kennedy B, Smith G. Cyclosporin neurotoxicity after chemotherapy. Case had features of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome. BMJ. 1999;319:54; author reply 54-55.
28. Reyes G, Fernandez-Yanez J, Rodriguez-Abella H, Palomo J, Pinto A, Duarte J. EVentricular assist devices as a bridge to transplantation-. Rev Esp Cardiol. 2007;60:72-75.
29. Sarmiento E, Rodriguez-Hernandez C, Rodriguez-Molina J, Fernandez-Yanez J, Palomo J, Anguita J, Perez JL, Lanio N, Fernandez-Cruz E, Carbone J. Impaired anti-pneumococcal polysaccharide antibody production and invasive pneumococcal infection following heart transplantation. Int Immunopharmacol. 2006;6:2027-2030.
30. Schober R, Herman MM. Neuropathology of cardiac transplantation. Survey of 31 cases. Lancet. 1973;1: 962-967.
31. Schwechheimer K, Hashemian A. Neuropathologic findings after organ transplantation. An autopsy study. Gen Diagn Pathol. 1995;141:35-39
32. Singh N, Aguado J, eds. Infectious Complications in Transplant Patients. 1st ed. Boston: Kluwer Academic Publishers; 2000:312.
33. Torre-Cisneros J, Doblas A, Aguado JM, San Juan R, Blanes M, Montejo M, Cervera C, Len O, Carratala J, Cisneros JM, Bou G, Munoz P, Ramos A, Gurgui M, Borrell N, Fortun J, Moreno A, Gavalda J. Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort. Clin Infect Dis. 2009;48:1657-1665.
34. Torre-Cisneros J, Lopez OL, Kusne S, Martinez AJ, Starzl TE, Simmons RL, Martin M. CNS aspergillosis in organ transplantation: a clinicopathological study. J Neurol Neurosurg Psychiatry. 1993;56:188-193.
35. Zierer A, Melby SJ, Voeller RK, Guthrie TJ, Al-Dadah AS, Meyers BF, Pasque MK, Ewald GA, Moon MR, Moazami N. Significance of neurologic complications in the modern era of cardiac transplantation. Ann Thorac Surg. 2007;83:1684-1690.